ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Complete Genomics appoints Lauren Selig to board ahead of Swiss Rockets deal

Selig joins as Swiss Rockets AG prepares to acquire the DNA sequencing firm, pending U.S. regulatory clearance. Her appointment reflects the deal's focus on precision healthcare and biotech innovation.

PA
Priya Anand · Equities & Earnings Desk · 20 Aug 2026 · 09:50 · 1 min read
Share
Complete Genomics appoints Lauren Selig to board ahead of Swiss Rockets deal

Complete Genomics said on Wednesday it appointed Lauren Selig to its board of directors, effective upon the completion of its pending acquisition by Swiss Rockets AG.

The acquisition, approved by Swiss Rockets’ board and shareholders, remains subject to clearance by the Committee on Foreign Investment in the United States, though it has already received approval from Chinese regulators. MGI Tech shareholders also approved the transaction, which is expected to close in the coming months.

Swiss Rockets, an incubator and accelerator specializing in biotech and precision healthcare—particularly oncology—will appoint Dr. Vladimir Cmiljanovic as chairman and CEO of Complete Genomics upon closing. Cmiljanovic, founder and CEO of Swiss Rockets, said Selig’s appointment strengthens the company’s strategic direction in frontier technologies and global innovation.

Selig, founder of Shake and Bake Productions, brings expertise in artificial intelligence, biotechnology, and emerging technologies to the board. Her investment fund has backed companies including LILA, Starcloud, Impulse Space, and Colossal, while she serves on the boards of XPRIZE, Pendrell, and Renatus Tactical Acquisition Corp. (NASDAQ: RTAC).

Beyond her business ventures, Selig has produced Academy Award-winning films such as Rocketman and Hacksaw Ridge, as well as Everest, Lone Survivor, and Amazon’s The Wheel of Time.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT